These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38881606)

  • 41. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-function relationship in early diabetic retinopathy: a spatial correlation analysis with OCT and microperimetry.
    Montesano G; Gervasoni A; Ferri P; Allegrini D; Migliavacca L; De Cillà S; Rossetti L
    Eye (Lond); 2017 Jun; 31(6):931-939. PubMed ID: 28257130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
    Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
    Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trial.
    Trento M; Durando O; Lavecchia S; Charrier L; Cavallo F; Costa MA; Hernández C; Simó R; Porta M;
    Endocrine; 2017 Jul; 57(1):83-88. PubMed ID: 27628581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
    Vorob'eva IV
    Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RP2-Associated X-linked Retinopathy: Clinical Findings, Molecular Genetics, and Natural History.
    Georgiou M; Robson AG; Jovanovic K; Guimarães TAC; Ali N; Pontikos N; Uwaydat SH; Mahroo OA; Cheetham ME; Webster AR; Hardcastle AJ; Michaelides M
    Ophthalmology; 2023 Apr; 130(4):413-422. PubMed ID: 36423731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy.
    Nisic F; Gadzo AP; Fajkic A; Nisic A; Miokovic AP; Damjanovic G; Begic E; Beslic N; Lepara O
    Rom J Ophthalmol; 2023; 67(3):283-288. PubMed ID: 37876512
    [No Abstract]   [Full Text] [Related]  

  • 49. Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy.
    Testa F; Carreño E; van den Born LI; Melillo P; Perea-Romero I; Di Iorio V; Risca G; Iodice CM; Pennings RJE; Karali M; Banfi S; Auricchio A; Galimberti S; Ayuso C; Simonelli F
    Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):25. PubMed ID: 38884554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Visual acuity is correlated with ischemia and neurodegeneration in patients with early stages of diabetic retinopathy.
    Li J; Zhou Y; Chen F; Li Y; Zhou R; Wu C; Yu H; Lin Z; Shi C; Zheng G; Shao Y; Chen Q; Lu F; Shen M
    Eye Vis (Lond); 2021 Oct; 8(1):38. PubMed ID: 34666831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin A and fish oils for preventing the progression of retinitis pigmentosa.
    Schwartz SG; Wang X; Chavis P; Kuriyan AE; Abariga SA
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD008428. PubMed ID: 32573764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contrast sensitivity and visual acuity under low light conditions in macular telangiectasia type 2.
    Müller S; Heeren TFC; Bonelli R; Fruttiger M; Charbel Issa P; Egan CA; Holz FG
    Br J Ophthalmol; 2019 Mar; 103(3):398-403. PubMed ID: 29858186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Low Luminance Questionnaire With Objective Functional Measures in Early and Intermediate Age-Related Macular Degeneration.
    Thompson AC; Luhmann UFO; Stinnett SS; Vajzovic L; Horne A; Toth CA; Cousins SW; Lad EM
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):289-297. PubMed ID: 29340643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mesopic foveal contrast sensitivity is impaired in diabetic patients without retinopathy.
    Katz G; Levkovitch-Verbin H; Treister G; Belkin M; Ilany J; Polat U
    Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1699-703. PubMed ID: 20499079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Visual Acuity Outcomes after Cataract Extraction with Intraocular Lens Implantation in Eyes with Diabetic Retinopathy.
    Han MM; Song W; Conti T; Conti FF; Greenlee T; Hom G; Briskin IN; Singh RP; Talcott KE
    Ophthalmol Retina; 2020 Apr; 4(4):351-360. PubMed ID: 32111544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset.
    Newman NJ; Yu-Wai-Man P; Carelli V; Moster ML; Biousse V; Vignal-Clermont C; Sergott RC; Klopstock T; Sadun AA; Barboni P; DeBusk AA; Girmens JF; Rudolph G; Karanjia R; Taiel M; Blouin L; Smits G; Katz B; Sahel JA;
    Ophthalmology; 2021 May; 128(5):649-660. PubMed ID: 33451738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
    Wong TY; Haskova Z; Asik K; Baumal CR; Csaky KG; Eter N; Ives JA; Jaffe GJ; Korobelnik JF; Lin H; Murata T; Ruamviboonsuk P; Schlottmann PG; Seres AI; Silverman D; Sun X; Tang Y; Wells JA; Yoon YH; Wykoff CC;
    Ophthalmology; 2024 Jun; 131(6):708-723. PubMed ID: 38158159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different lasers and techniques for proliferative diabetic retinopathy.
    Moutray T; Evans JR; Lois N; Armstrong DJ; Peto T; Azuara-Blanco A
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012314. PubMed ID: 29543992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema.
    Sabeti F; Rai BB; van Kleef JP; Rohan EMF; Carle CF; Barry RC; Essex RW; Nolan CJ; Maddess T
    PLoS One; 2023; 18(6):e0287319. PubMed ID: 37319294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.